Latest PEG ratio for Hangzhou Alltest Biotech , Ltd.: -53.81 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-53.81
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for 688606.SS is -53.81. That is below the sector sector average of 10.05. Investors often review this figure alongside Hangzhou Alltest Biotech , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Against its sector companies, 688606.SS currently prints -53.81 for PEG ratio, while the sector average sits near 10.05. That is roughly 635.2% below the sector mean. Large gaps often invite a closer look at Hangzhou Alltest Biotech , Ltd.'s growth, margins, and balance sheet.
A PEG ratio of -53.81 for Hangzhou Alltest Biotech , Ltd. is not 'good' or 'bad' on its own. Compare it with the peer average (10.05) and with 688606.SS's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting 688606.SS's PEG ratio (-53.81), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.